Search

everythinglearnresearchcommunity

for

Search:↓

Women aged 21-26 have a higher rate of PCOS.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Women losing hair might have lower levels of vitamin D.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

Fenugreek extract may help treat benign prostatic hyperplasia.

Treating hyperprolactinemia can help manage PCOS symptoms.

Trazodone might help reverse post finasteride syndrome.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

PCOS is common, affects fertility, and needs early diagnosis and lifestyle changes for management.